Catalyst Pharmaceuticals, Inc. Share Price
Stocks
CPRX
US14888U1016
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +0.03% |
|
0.00% | +34.92% |
| 07-16 | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | MT |
| 07-16 | Deals of the day-Mergers and acquisitions | RE |
| Market Cap | 3.85B 3.35B 3.11B 2.87B 5.4B 368B 5.5B 36.81B 14.41B 183B 14.48B 14.16B 615B | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.15B 2.73B 2.54B 2.34B 4.41B 301B 4.49B 30.07B 11.77B 149B 11.82B 11.57B 502B | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.03% | ||
| Current month | +0.19% | ||
| 1 month | +0.19% | ||
| 3 months | +11.94% | ||
| 6 months | +29.59% | ||
| Current year | +34.92% |
| 1 month | 31.44 |  | 31.5 |
| Current year | 22.13 | | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.7 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 31/12/2023 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 31/12/2023 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 14/07/2026 | |
Massimo Marin
BRD | Director/Board Member | - | 14/07/2026 |
Enrica Dogali
BRD | Director/Board Member | - | 14/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Issuer sale | Director | -63,583 | 0.0519% | ||
| 15/07/26 | Issuer sale | Director | -130,857 | 0.1069% | ||
| 15/07/26 | Issuer sale | Executive/Senior Manager | -1,051,183 | 0.8587% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | 0.00% | +47.98% | +125.41% | 3.85B | |
| -0.12% | +12.45% | +35.24% | -0.57% | 75.12B | |
| +3.59% | -8.58% | +18.09% | +179.31% | 47.63B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 49.48B | |
| -3.81% | +6.32% | -54.61% | -53.87% | 42.95B | |
| -1.96% | +0.81% | +59.23% | -24.56% | 30.72B | |
| -2.92% | +1.25% | +59.09% | +86.98% | 24.93B | |
| -0.21% | +7.53% | +96.68% | -50.59% | 22.98B | |
| -1.59% | -4.78% | -11.93% | +136.89% | 19.56B | |
| -0.06% | +3.02% | +74.78% | +128.74% | 17.19B | |
| Average | -0.98% | +2.34% | +37.31% | +57.62% | 33.44B | |
| Weighted average by Cap. | -0.95% | +3.29% | +30.85% | +42.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 492M 427M 397M 366M 689M 46.95B 702M 4.7B 1.84B 23.32B 1.85B 1.81B 78.41B | 589M 512M 475M 438M 825M 56.23B 840M 5.62B 2.2B 27.93B 2.21B 2.16B 93.92B |
| Net income | 164M 142M 132M 122M 230M 15.65B 234M 1.57B 613M 7.77B 615M 602M 26.13B | 214M 186M 173M 159M 300M 20.46B 306M 2.05B 801M 10.16B 805M 787M 34.17B |
| Net Debt | -514M -447M -415M -383M -721M -49.11B -734M -4.91B -1.92B -24.39B -1.93B -1.89B -82.02B | -706M -614M -570M -525M -990M -67.44B -1.01B -6.75B -2.64B -33.49B -2.65B -2.59B -113B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
